ARANESP

Google image searchProduct monograph

Active ingredient

darbepoetin alfa, 40 MCG/ML

DIN: 02392321

Dosage form(s): SOLUTION

Route(s) of administration: INTRAVENOUS, SUBCUTANEOUS

Description: HSA-FREE. 20 MCG/0.5ML SINGLE-USE PREFILLED SYRINGES (SINGLEJECT)

Schedule: Prescription / Schedule D

Company: AMGEN CANADA INC

Date: 12-MAR-2014

ATC:

Reference brand drug: Aranesp

Search on Google